This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
DexCom, Inc. (Nasdaq:DXCM) announced today that it has entered into a definitive agreement to acquire SweetSpot Diabetes Care, Inc., a healthcare-focused information technology company, in an all stock transaction, with initial consideration of up to $4.5 million and performance milestone-based earnout consideration of up to an additional $4 million. SweetSpot has an advanced cloud-based platform for uploading and processing data and specializes in turning raw output from patient devices into powerful information for healthcare providers, patients and researchers. The SweetSpot platform is comprised of the 510(k) cleared SweetSpot Diabetes Data Management Service, a secure end-to-end solution for diabetes data management, automating the retrieval of data from numerous patient devices; managing, processing and storing data in the cloud; and integrating into electronic medical records and other clinical systems for information delivery. The platform is vendor-neutral and data from most common blood glucose meters can be retrieved during a step-by-step session at a physical kiosk in a clinic or through a web-based application. As we work with SweetSpot to build out the platform, we expect to incorporate CGM and insulin data with simplified reporting capabilities and easy, secure data access for patients and their healthcare providers.
“The acquisition of SweetSpot represents another step forward in our mission to make the lives of people living with diabetes, and those caring for them, more convenient,” said Terrance H. Gregg, Chief Executive Officer of DexCom. “Our customers consistently ask for new and better tools to support the gathering and interpretation of health-related data, as it is clear that diabetes care must and will be transformed with the help of connected monitoring devices and more sophisticated, yet simplified, use of data by healthcare providers, patients and payers.” Mr. Gregg continued, “While we believe we are firmly entrenched as the world’s leading glucose sensor technology, from a competitive perspective, our two missing pieces remain insulin pump integration in the U.S. and a universal data management system. Our acquisition of SweetSpot combined with our insulin pump partnerships will fill these voids. Our ultimate objective is to move a patient’s CGM data directly and seamlessly from the patient’s phone or CGM receiver to our cloud-based platform. Not only will this cloud-based data provide patients and providers with much more useful information, it will greatly enhance DexCom’s ability to monitor our product performance and measure patient utilization patterns.”